For citation:
. . FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2012;5(2):3-8. (In Russ.)
Views: 104
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Fullscreen
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Author
Keywords
COPD
NAFLD
NASH
Pharmacoeconomics
QALY
budget impact analysis
chemotherapy
children
clinical and economic analysis
cost-effectiveness analysis
cost-utility analysis
drug supply
drugs
health technology assessment
indirect comparison
non-alcoholic fatty liver disease
pharmacoeconomic analysis
pharmacoeconomic studies
pharmacoeconomics
pharmacoepidemiology
rare diseases
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
